Literature DB >> 28055897

Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.

.   

Abstract

Different types of genomic aberration may simultaneously contribute to tumorigenesis. To obtain a more accurate prognostic assessment to guide therapeutic regimen choice for cancer patients, the heterogeneous multi-omics data should be integrated harmoniously, which can often be difficult. For this purpose, we propose a Gene Interaction Regularized Elastic Net (GIREN) model that predicts clinical outcome by integrating multiple data types. GIREN conveniently embraces both gene measurements and gene-gene interaction information under an elastic net formulation, enforcing structure sparsity, and the "grouping effect" in solution to select the discriminate features with prognostic value. An iterative gradient descent algorithm is also developed to solve the model with regularized optimization. GIREN was applied to human ovarian cancer and breast cancer datasets obtained from The Cancer Genome Atlas, respectively. Result shows that, the proposed GIREN algorithm obtained more accurate and robust performance over competing algorithms (LASSO, Elastic Net, and Semi-supervised PCA, with or without average pathway expression features) in predicting cancer progression on both two datasets in terms of median area under curve (AUC) and interquartile range (IQR), suggesting a promising direction for more effective integration of gene measurement and gene interaction information.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 28055897      PMCID: PMC5374042          DOI: 10.1109/TCBB.2015.2511758

Source DB:  PubMed          Journal:  IEEE/ACM Trans Comput Biol Bioinform        ISSN: 1545-5963            Impact factor:   3.710


  38 in total

1.  Leveraging external knowledge on molecular interactions in classification methods for risk prediction of patients.

Authors:  Christine Porzelius; Marc Johannes; Harald Binder; Tim Beissbarth
Journal:  Biom J       Date:  2011-02-17       Impact factor: 2.207

Review 2.  Identification of RNA-protein interaction networks using PAR-CLIP.

Authors:  Manuel Ascano; Markus Hafner; Pavol Cekan; Stefanie Gerstberger; Thomas Tuschl
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-12-27       Impact factor: 9.957

3.  Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains.

Authors:  Benjamin P Berman; Daniel J Weisenberger; Joseph F Aman; Toshinori Hinoue; Zachary Ramjan; Yaping Liu; Houtan Noushmehr; Christopher P E Lange; Cornelis M van Dijk; Rob A E M Tollenaar; David Van Den Berg; Peter W Laird
Journal:  Nat Genet       Date:  2011-11-27       Impact factor: 38.330

4.  Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer.

Authors:  Gary C Hon; R David Hawkins; Otavia L Caballero; Christine Lo; Ryan Lister; Mattia Pelizzola; Armand Valsesia; Zhen Ye; Samantha Kuan; Lee E Edsall; Anamaria Aranha Camargo; Brian J Stevenson; Joseph R Ecker; Vineet Bafna; Robert L Strausberg; Andrew J Simpson; Bing Ren
Journal:  Genome Res       Date:  2011-12-07       Impact factor: 9.043

5.  Including network knowledge into Cox regression models for biomarker signature discovery.

Authors:  Holger Fröhlich
Journal:  Biom J       Date:  2014-01-15       Impact factor: 2.207

6.  Network information improves cancer outcome prediction.

Authors:  Janine Roy; Christof Winter; Zerrin Isik; Michael Schroeder
Journal:  Brief Bioinform       Date:  2012-12-18       Impact factor: 11.622

7.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

8.  Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer.

Authors:  Stephan Gade; Christine Porzelius; Maria Fälth; Jan C Brase; Daniela Wuttig; Ruprecht Kuner; Harald Binder; Holger Sültmann; Tim Beissbarth
Journal:  BMC Bioinformatics       Date:  2011-12-21       Impact factor: 3.169

9.  Integrative subtype discovery in glioblastoma using iCluster.

Authors:  Ronglai Shen; Qianxing Mo; Nikolaus Schultz; Venkatraman E Seshan; Adam B Olshen; Jason Huse; Marc Ladanyi; Chris Sander
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

Review 10.  High-throughput sequencing for biology and medicine.

Authors:  Wendy Weijia Soon; Manoj Hariharan; Michael P Snyder
Journal:  Mol Syst Biol       Date:  2013       Impact factor: 11.429

View more
  4 in total

Review 1.  The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine.

Authors:  Kivilcim Ozturk; Michelle Dow; Daniel E Carlin; Rafael Bejar; Hannah Carter
Journal:  J Mol Biol       Date:  2018-06-15       Impact factor: 5.469

2.  Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer.

Authors:  Xiao-Hong Yin; Ying-Hui Jin; Yue Cao; York Wong; Hong Weng; Chao Sun; Jun-Hao Deng; Xian-Tao Zeng
Journal:  Front Oncol       Date:  2019-08-07       Impact factor: 6.244

3.  Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects.

Authors:  Ruyang Zhang; Chao Chen; Xuesi Dong; Sipeng Shen; Linjing Lai; Jieyu He; Dongfang You; Lijuan Lin; Ying Zhu; Hui Huang; Jiajin Chen; Liangmin Wei; Xin Chen; Yi Li; Yichen Guo; Weiwei Duan; Liya Liu; Li Su; Andrea Shafer; Thomas Fleischer; Maria Moksnes Bjaanæs; Anna Karlsson; Maria Planck; Rui Wang; Johan Staaf; Åslaug Helland; Manel Esteller; Yongyue Wei; Feng Chen; David C Christiani
Journal:  Chest       Date:  2020-02-28       Impact factor: 9.410

4.  Elastic Net-Based Identification of a Multigene Combination Predicting the Survival of Patients with Cervical Cancer.

Authors:  Hua Wang; Shu-Wei Li; Wei Li; Hong-Bing Cai
Journal:  Med Sci Monit       Date:  2019-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.